BN Agrochem Ltd Forensic Report - SOIC x StockScans Report

as of Sep 2026

BN Agrochem's record shows a company whose public filings and shareholder approvals tell sharply different stories. The standalone audit opinions have been qualified for four straight years, while the board's own reports claim the opposite. The movement of ₹283.75 crore into a newly created UK subsidiary alongside a scheme pulling three promoter-linked companies into the listed entity is a significant issue.

Key findings

  1. ₹283.75 crore moved to a new UK subsidiary while promoter-linked firms are being amalgamated Critical - BN Agrochem had no subsidiaries from FY2019-20 through FY2022-23. It incorporated BN Holdings Europe Limited in London on February 17, 2024, and invested USD 34 million (₹283.75 crore) into it during FY2024-25, which is approximately 0.32 times FY26 revenue of ₹873 crore. On June 28, 2025, the board approved a scheme to amalgamate A1 Agri Global Limited, B.N. Agritech Limited, and Salasar Balaji Overseas Private Limited into the listed entity.
  2. Qualified standalone opinions in four years despite board reports claiming no qualifications Major - The standalone auditor's reports for FY2022, FY2024, FY2025 and FY2026 each state a qualified opinion "except for the possible effects of the matters described in the 'Basis for Opinion' section". The Board's Reports for the same years state the auditors' report "contains no qualification, reservation, adverse remark or disclaimer". The consolidated opinions for FY2024, FY2025 and FY2026 are unqualified.
  3. Shareholder approvals for up to ₹500 crore per party in related-party loans against revenue of ₹7 crore Major - At the AGM notice dated August 31, 202,300 crore Agrochem sought approval for loans and related-party transactions up to ₹500 crore per company per year to five promoter-linked companies, with the source of funds stated as "Investments received from GLOBAL FOCUS FUND". The notice disclosed the transaction value as "NIL" percentage of consolidated turnover. The FY2026 AGM notice dated September 1, 2026 seeks ratification of related-party transactions up to ₹100 crore each for 3 years, disclosing that Epitome Industries India Limited had nil turnover and a loss of 1.28 crore in FY2025-26.
  4. Operating cash flow failed to cover profit, while ₹290 crore sits with an EPC contractor for an incomplete project Major - In FY202,400-2,500 crore Agrochem reported PAT of ₹19.76 crore but operating cash flow of negative ₹31.27 crore. As at March 31, 2025, capital advances stood at 290.12 crore, a 10% advance to a third-party EPC contractor for a proposed Edible Oil Refinery and Oleo Chemical Complex, with land acquisition still ongoing. In the latest period, other income of ₹9 crore represented 568.9% of PBT of ₹2 crore.
  5. Statutory auditor resigned mid-tenure in August 2023; replacement approved for five years Major - M/s R.B. Pandya & Associates, appointed for a five-year term from the 31st AGM, filed resignation on August 25, 2023, effective October 30, 2023. M/s JSMG & Associates was appointed to fill the casual vacancy and shareholders approved a five-year term through FY2028-29 at the AGM held September 24, 2024, with 100% votes in favour. JSMG signed the FY2025-26 and FY2024-25 standalone reports with qualified opinions and no basis.
  6. Board repeatedly reconstituted around promoter Anubhav Agarwal since his 2022 takeover Major - Mr. Anubhav Agarwal acquired control on November 11, 2022, with 56.80% holding. He was re-designated from Managing Director to Non-Executive Director effective May 21, 2025, the same date Mr. Chintan Ajaykumar Shah was appointed Whole-time Director and Mr. Ashutosh Sharma resigned. CFO turnover occurred twice in three years: Mrs. Manisha resigned effective May 31, 2026, and Mr. Anurag Bansal was appointed effective June 1, 2026. At the September 29, 2025 AGM, public non-institutions polled only 39,078 votes out of 91,972,941 shares held (0.0425%) on the re-appointment of Mr. Agarwal.
  7. Extreme customer concentration and receivables swung from nil to 288.86 crore with no impairment allowance Major - Consolidated trade receivables were nil as at March 31, 2024, rising to 288.86 crore gross as at March 31, 2025 with no loss allowance. Two customers, Vinay Enterprises and Arasum Agrochem Pvt Ltd, accounted for 40.33% of FY2025 revenue. Revenue recognition includes "Gain on washout arrangement," being the difference between original and revised price when a contract is mutually cancelled and goods resold or repurchased, often to or from the same party.

What to watch

Bottom line: This is a record of a company whose shareholder approvals consistently authorise far more related-party exposure than its own revenue could justify, and whose audit opinions have been qualified for four years despite board reports claiming no qualifications. The risk character is one of fund movement between the listed entity and promoter-linked parties, with the amalgamation scheme and the UK subsidiary investment as the two channels to watch. The next annual report will show whether the audit qualification gains a basis and whether the statutory auditor's resignation mid-tenure is followed by a stable replacement.